Our research interests are diverse.  The examples of current projects include:

• The role of the extravascular extracellular fluid in the accelerated aging process
• Geographic altitude and headaches
• Alzheimer's disease and atherosclerosis
• Alzheimer's disease, EPO and altitude
• Geographic altitude and vision
• Alzheimer's disease and various comorbidities 
• Enhancing shared decision making in health care 

Our collaborators

• Dr. Álvaro Aceña is Associate Professor of Cardiology in University of Madrid. Dr. Acena published numerous peer-reviewed publications in the field of experimental cardiology, cardiac amyloidosis etc.

• Dr. Pere Gascón, M.D, Ph.D is a Director of the Chair of Oncology and Multidisciplinary Knowledge, University of Barcelona. He is also a Senior Consultant, Department Hematology-Oncology, Hospital Clínic, Professor in Medicine and Director Laboratory of Molecular & Translational Oncology-CELLEX. Professor Gascon published numerous important papers focused on biologics and biosimilars.

• Dr. Rovshan Ismailov, M.D, M.P.H., Ph.D is a director at the CMDAT Foundation. He is a medical doctor, epidemiologist and public health practitioner who graduated with PhD in Epidemiology from University of Pittsburgh and Master’s in Public Health from Boston University. In 2015-2017 he presented more than 70 community based seminars related to various health issues. Dr. Ismailov has published many important research findings from his studies in such peer-reviewed journals as “American Journal of Kidney Disease”, “American Heart Journal”, “Annals of Neurology” etc.

• Dr. Zaytuna Khasanova, MD, is the research scientist at the CMDAT Research Foundation. She is a medical doctor with more than 30 years of clinical and research experience. She conducted numerous clinical studies in the field of cardiology and preventive medicine. Dr. Khasanova published numerous peer-reviewed publications in the field of experimental cardiology, cardiovascular epidemiology and clinical science.

• Dr. Jan Lerut, MD, PhD; Professor emeritus of Surgery. He has served as president of the Belgian Society of Transplantation, the Royal Belgian Society of Surgery, the Eurotransplant Liver Allocation Committee (ELIAC),the European Society for Organ Transplantation (ESOT), the International Liver Transplantation Society (ILTS) and the International Living Donor Liver Transplantation Study Group (iLDLT-SG).He is vice-chair of the UEMS-European Board of Transplantation Surgery (EBTS) and member of the Belgian Superior Health Council. He is member of 22 learning societies related to surgery and transplantation, several councils, scientific committees (e.g. Transmet colorectal metatstases transplantation project, European University Diploma Hepatic, pancreatic and biliary onco-surgical strategies, UEMS-European Board Transplantation Surgery).He has published over 350 peer-reviewed articles, he authored 24 books chapters and 24 scientific films. He made more than 750 communications on national and international congresses, most of them devoted to liver transplantation.

• Dr. Judy Lytle earned her PhD in Interdisciplinary Neuroscience from Georgetown University Medical Center in Washington D.C., USA, where she studied traumatic injury to the central nervous system. She is currently a senior medical science liason at Adamas Pharmaceuticals.

• Dr. Marcio Nucci is Professor of Medicine at Federal University of Rio de Janeiro, Brazil, and has been responsible for the Program of Infection in the Hematology and Bone Marrow Transplantation unit at the University Hospital for over 25 years. He has received his medical degree in 1981 from the Federal University of Rio de Janeiro State, has completed his residency in Hematology at Federal University of Rio de Janeiro in 1985 and has trained in Infectious Diseases at Università la Sapienza, Roma, Italy in 1991. Professor Marcio Nucci has published over 200 peer-reviewed articles, and has been speaker in several medical conferences. He is past member of the Immunocompromised Host Society Council and the Mycosis Study Group Steering and Educational Committees, and is a reviewer of various medical scientific journals.

• Dr.  Lieven Pouillon is a gastroenterologist-hepatologist at the IBD Clinic and GI Clinical Research Centre, Imelda General Hospital, Bonheiden, Belgium He is the lead author of “Consensus report: clinical recommendations for the prevention and management of the nocebo effect in biosimilar-treated IBD patients”. Dr Pouillon graduated as a gastroenterologist at K.U. Leuven (Belgium). He has (co-)authored >40 publications (h-index 14), presented at >10 international congresses, and has clinical trial experience as a principal and sub-investigator in over 25 international trials. Dr Pouillon is an elected member of the educational committee of the Belgian Inflammatory Bowel Disease Research and Development Group (BIRD) and serves as a reviewer for several leading gastroenterology journals, including CGH, AP&T and JCC.

• Dr. Dyana Saenz is a research scientist at the University of Texas MD Anderson Cancer Center Dr. Saenz is a Ph.D. trained research scientist with experience in HIV biology, cancer biology, gene therapy, and therapeutic discovery. Dr. Saenz published numerous important research papers focuses on synergistic drug combinations for the treatment of myeloproliferative neoplasm (MPN), acute myeloid leukemia (AML), and mantle cell lymphoma (MCL).

• Dr. Christian Sellinger works as a Consultant Gastroenterologist in Leeds. He completed gastroenterology training in Manchester and advanced training in Inflammatory Bowel Disease in Sydney, Australia. He was awarded an MD from the University of Manchester for his research on IBD in 2013 and an MSc with distinction in Gastroenterology from the University of Salford in 2011. His research expertise lies within Gastroenterology, especially Inflammatory Bowel Disease and endoscopy. Dr. Christian Selinger has researched and published widely in the field of Gastroenterology. He has authored and co-authored 30 papers in peer-reviewed journals and presented more than 50 abstracts at international meetings.

• Dr. Steven Simoens is currently Professor of Health Economics at KU Leuven.  He is a Commercial Engineer (KU Leuven, 1997), who later specialised in health economics and obtained a MSc in Health Economics (University of York, 1998) and a PhD in Economics (University of Aberdeen, 2001). The research interests of Steven Simoens focus on health economic aspects of medicinal products. Steven Simoens has carried out numerous cost(-of-illness) analyses, economic evaluations and budget impact analyses of medicinal products. He has also worked extensively in the area of policy relating to market access of medicinal products, with a particular interest in oncology medicinal products, orphan medicinal products, generic and biosimilar medicinal products, and shortages of medicinal products. Professor Simoens is one of the founders of the KU Leuven Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL)